- Home
- NMRA vs FRST Comparison
NMRA vs FRST Comparison
Compare NMRA & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- FRST
- Stock Information
- Founded
- NMRA 2019
- FRST 2004
- Country
- NMRA United States
- FRST United States
- Employees
- NMRA N/A
- FRST N/A
- Industry
- NMRA
- FRST Major Banks
- Sector
- NMRA
- FRST Finance
- Exchange
- NMRA Nasdaq
- FRST Nasdaq
- Market Cap
- NMRA 121.0M
- FRST 265.8M
- IPO Year
- NMRA 2023
- FRST 2006
- Fundamental
- Price
- NMRA $1.03
- FRST $11.34
- Analyst Decision
- NMRA Buy
- FRST Buy
- Analyst Count
- NMRA 8
- FRST 1
- Target Price
- NMRA $9.29
- FRST $420.00
- AVG Volume (30 Days)
- NMRA 1.4M
- FRST 84.5K
- Earning Date
- NMRA 08-05-2025
- FRST 07-24-2025
- Dividend Yield
- NMRA N/A
- FRST 3.52%
- EPS Growth
- NMRA N/A
- FRST N/A
- EPS
- NMRA N/A
- FRST 0.16
- Revenue
- NMRA N/A
- FRST $125,133,000.00
- Revenue This Year
- NMRA N/A
- FRST $21.33
- Revenue Next Year
- NMRA N/A
- FRST $12.77
- P/E Ratio
- NMRA N/A
- FRST $70.69
- Revenue Growth
- NMRA N/A
- FRST 22.34
- 52 Week Low
- NMRA $0.61
- FRST $7.59
- 52 Week High
- NMRA $17.19
- FRST $13.52
- Technical
- Relative Strength Index (RSI)
- NMRA 67.61
- FRST 74.61
- Support Level
- NMRA $0.72
- FRST $10.40
- Resistance Level
- NMRA $0.85
- FRST $11.40
- Average True Range (ATR)
- NMRA 0.08
- FRST 0.25
- MACD
- NMRA 0.02
- FRST 0.07
- Stochastic Oscillator
- NMRA 100.00
- FRST 96.45
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit. Its operating segments are Primis Mortgage, Primis Bank, and Other.